Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2015-07-15 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-07-15 English
FORM 4
Director's Dealing
2015-07-13 English
BALCHEM CORPORATION 11-K 12-31-2014
Annual Report Classification · 100% confidence The document is titled 'FORM 11-K' and explicitly states it is an annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2014. It pertains to the Balchem Corporation 401(k) Profit Sharing Plan and includes detailed financial statements, notes, and an independent auditor's report. The 11-K form is a specific annual report for employee stock purchase, savings, and similar plans, filed with the SEC. This matches the definition of an Annual Report (10-K) type filing, but specifically the 11-K is a type of annual report for employee benefit plans. Given the specificity and the nature of the document as a full annual report with financial statements and audit opinion, the best fitting category is Annual Report (10-K).
2015-06-29 English
BALCHEM CORPORATION 8-K 6-17-2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 17, 2015, reporting the results of the Annual Meeting of Stockholders. It details the voting outcomes for director elections, ratification of the independent auditor, and advisory vote on executive compensation. The content is focused on the official results of shareholder votes at the Annual Meeting, which matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2784 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, the correct classification is DVA.
2015-06-18 English
FORM 4
Director's Dealing
2015-06-15 English
FORM 4
Director's Dealing
2015-06-12 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.